rs11599164

Positions:

chr10-60072226-G-T

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1

The ENST00000280772.7(ANK3):c.8655C>A(p.His2885Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0921 in 1,613,942 control chromosomes in the GnomAD database, including 7,869 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.

Frequency

Genomes: 𝑓 0.072 ( 546 hom., cov: 32)

Exomes 𝑓: 0.094 ( 7323 hom. )

Consequence

ANK3
ENST00000280772.7 missense

Scores

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 2.43

Variant links:

Genes affected

ANK3 (HGNC:494): (ankyrin 3) Ankyrins are a family of proteins that are believed to link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact, and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 3 is an immunologically distinct gene product from ankyrins 1 and 2, and was originally found at the axonal initial segment and nodes of Ranvier of neurons in the central and peripheral nervous systems. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]

ANK3 links:

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

PP2

Missense variant in gene, where missense usually causes diseases (based on misZ statistic), ANK3. . Gene score misZ 2.7937 (greater than the threshold 3.09). Trascript score misZ 5.3471 (greater than threshold 3.09). GenCC has associacion of gene with intellectual disability, Tourette syndrome, intellectual disability-hypotonia-spasticity-sleep disorder syndrome.

BP4

Computational evidence support a benign effect (MetaRNN=0.001482755).

BP6

Variant 10-60072226-G-T is Benign according to our data. Variant chr10-60072226-G-T is described in ClinVar as [Benign]. Clinvar id is 128379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

BA1

GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.11 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	Protein	UniProt
ANK3	NM_020987.5 linkuse as main transcript	c.8655C>A	p.His2885Gln	missense_variant	37/44	ENST00000280772.7	NP_066267.2

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Protein	Appris	UniProt
ANK3	ENST00000280772.7 linkuse as main transcript	c.8655C>A	p.His2885Gln	missense_variant	37/44	1	NM_020987.5	ENSP00000280772		Q12955-3

Frequencies

GnomAD3 genomes

AF:

0.0718

AC:

10926

AN:

152092

Hom.:

546

Cov.:

show subpopulations

Gnomad AFR

AF:

0.0198

Gnomad AMI

AF:

0.0779

Gnomad AMR

AF:

0.0726

Gnomad ASJ

AF:

0.0574

Gnomad EAS

AF:

0.000193

Gnomad SAS

AF:

0.0172

Gnomad FIN

AF:

0.0778

Gnomad MID

AF:

0.0728

Gnomad NFE

AF:

0.112

Gnomad OTH

AF:

0.0765

GnomAD3 exomes

AF:

0.0720

AC:

17972

AN:

249760

Hom.:

905

AF XY:

0.0722

AC XY:

9770

AN XY:

135354

show subpopulations

Gnomad AFR exome

AF:

0.0175

Gnomad AMR exome

AF:

0.0509

Gnomad ASJ exome

AF:

0.0615

Gnomad EAS exome

AF:

0.000218

Gnomad SAS exome

AF:

0.0209

Gnomad FIN exome

AF:

0.0820

Gnomad NFE exome

AF:

0.109

Gnomad OTH exome

AF:

0.0957

GnomAD4 exome

AF:

0.0942

AC:

137669

AN:

1461732

Hom.:

7323

Cov.:

AF XY:

0.0924

AC XY:

67209

AN XY:

727174

show subpopulations

Gnomad4 AFR exome

AF:

0.0150

Gnomad4 AMR exome

AF:

0.0542

Gnomad4 ASJ exome

AF:

0.0633

Gnomad4 EAS exome

AF:

0.000202

Gnomad4 SAS exome

AF:

0.0213

Gnomad4 FIN exome

AF:

0.0854

Gnomad4 NFE exome

AF:

0.109

Gnomad4 OTH exome

AF:

0.0855

GnomAD4 genome

AF:

0.0717

AC:

10920

AN:

152210

Hom.:

546

Cov.:

AF XY:

0.0673

AC XY:

5010

AN XY:

74426

show subpopulations

Gnomad4 AFR

AF:

0.0198

Gnomad4 AMR

AF:

0.0726

Gnomad4 ASJ

AF:

0.0574

Gnomad4 EAS

AF:

0.000193

Gnomad4 SAS

AF:

0.0168

Gnomad4 FIN

AF:

0.0778

Gnomad4 NFE

AF:

0.112

Gnomad4 OTH

AF:

0.0757

Alfa

AF:

0.0997

Hom.:

2056

Bravo

AF:

0.0687

TwinsUK

AF:

0.108

AC:

401

ALSPAC

AF:

0.0983

AC:

379

ESP6500AA

AF:

0.0188

AC:

ESP6500EA

AF:

0.109

AC:

934

ExAC

AF:

0.0741

AC:

8990

Asia WGS

AF:

0.0160

AC:

AN:

3478

ClinVar

Significance: Benign

Submissions summary: Benign:4

Revision: criteria provided, multiple submitters, no conflicts

LINK: link

Submissions by phenotype

not provided

Benign:2

Benign, criteria provided, single submitter	not provided	Breakthrough Genomics, Breakthrough Genomics	-	- -
Benign, criteria provided, single submitter	clinical testing	Labcorp Genetics (formerly Invitae), Labcorp	Jan 30, 2024	- -

not specified

Benign:1

Likely benign, no assertion criteria provided

clinical testing

Genetic Services Laboratory, University of Chicago

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

ANK3-related disorder

Benign:1

Benign, no assertion criteria provided

clinical testing

PreventionGenetics, part of Exact Sciences

Nov 25, 2019

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

AlphaMissense

Benign

0.13

BayesDel_addAF

Benign

-0.57

BayesDel_noAF

Benign

-0.49

CADD

Benign

DANN

Benign

0.92

DEOGEN2

Benign

0.24

Eigen

Benign

-0.17

Eigen_PC

Benign

0.074

FATHMM_MKL

Uncertain

0.87

LIST_S2

Benign

0.71

MetaRNN

Benign

0.0015

MetaSVM

Benign

-1.1

MutationAssessor

Benign

1.8

MutationTaster

Benign

1.0

D;D;D;N

PrimateAI

Benign

0.36

PROVEAN

Benign

-0.090

REVEL

Benign

0.081

Sift

Uncertain

0.0090

Polyphen

0.0030

Vest4

0.091

MutPred

0.096

Loss of catalytic residue at H2885 (P = 0.1063);

MPC

0.14

ClinPred

0.021

GERP RS

5.7

Varity_R

0.068

gMVP

0.096

Splicing

Name

Calibrated prediction

Score

Prediction

SpliceAI score (max)

0.0

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

LitVar

Other links and lift over